How to Help Your Patients Find Trijardy XR in Stock: A Provider's Guide

Patients prescribed Trijardy XR are increasingly contacting their providers when they cannot fill their prescriptions. For clinicians managing busy outpatient diabetes panels, this can generate significant callback volume and workflow disruption. This guide provides a structured approach to minimizing that burden — with practical tools, substitution logic, and patient-facing resources.

Why Patients Can't Fill Trijardy XR

Trijardy XR is a brand-name-only product (no generic as of 2026) with no therapeutic substitute at the pharmacy level — meaning pharmacists cannot automatically swap it out. When it's not in stock, the patient must either find it elsewhere or contact their prescriber for an alternative. The root causes include high demand for empagliflozin-containing products, single-source manufacturing by Boehringer Ingelheim, and the high acquisition cost that leads smaller pharmacies to avoid keeping it as standing inventory.

Step 1: Enable Patients to Self-Check Pharmacy Availability

The simplest first step is directing patients to check pharmacy availability themselves using medfinder. medfinder contacts pharmacies in the patient's area, asks which ones can fill their specific prescription, and texts results directly to the patient. This self-service step resolves many availability issues without requiring a callback to the provider's office.

For your practice, medfinder for providers integrates this capability into your workflow — allowing you to check stock before routing a prescription to a specific pharmacy, dramatically reducing patient callbacks.

Step 2: Create a Standardized Triage Protocol for Pharmacy Callbacks

When a patient calls your office because Trijardy XR is out of stock, staff should follow a consistent triage flow:

1. Ask: How many days of medication does the patient have left? If more than 5 days, they can afford to search for their prescription without clinical urgency.
2. Direct the patient to medfinder or suggest they call 2-3 independent pharmacies with the exact strength and quantity on their prescription.
3. If still unavailable after 2 business days, escalate to the prescriber for a bridge or substitution decision.
4. If the patient has fewer than 3 days of medication left, escalate immediately — do not delay for self-service steps.

Step 3: Know Your Substitution Options

When a bridge or substitution is needed, your choice depends on the patient's clinical indication. The most important clinical split is whether the patient is taking Trijardy XR primarily for glycemic control or also for cardiovascular risk reduction:

For Patients With Established CVD or High CV Risk (Keep SGLT2 Coverage)

• First choice: Glyxambi (empagliflozin/linagliptin) + generic metformin ER — preserves all three components, maintains empagliflozin's CV benefit
• Second choice: Farxiga 10 mg (dapagliflozin) + Tradjenta 5 mg (linagliptin) + generic metformin ER — switches SGLT2 inhibitor but maintains coverage for all three drug classes
• Synjardy XR (empagliflozin/metformin ER) + Tradjenta 5 mg — preserves empagliflozin, adds linagliptin separately

For Patients Whose Primary Goal Is Glycemic Control Only

• Generic sitagliptin/metformin ER (Janumet XR generic) — affordable, widely available, covers DPP-4 + biguanide. Note: sitagliptin requires renal dose adjustment; linagliptin does not.
• Tradjenta 5 mg + generic metformin ER (separate pills) — maintains the exact linagliptin + metformin components from Trijardy XR, no SGLT2 inhibitor

Step 4: Keep Manufacturer Samples as a Bridge

Contact your Boehringer Ingelheim pharmaceutical representative to ensure you maintain an adequate sample supply of Trijardy XR, Glyxambi, and Tradjenta. Samples can provide a 1-2 week bridge while the patient locates their prescription or while a new PA processes. Document sample dispensing in the medical record per your practice policy.

Step 5: Recommend Mail-Order Pharmacy for Ongoing Patients

For patients who consistently take Trijardy XR, a 90-day mail-order supply is more resistant to localized stock-outs. Many commercial plans and Medicare Part D plans offer lower cost-sharing for mail-order fills. At the next visit, proactively recommend mail-order to your stable Trijardy XR patients — it eliminates the repeated availability headache for both the patient and your office.

Sample Script for Front-Desk Staff

"I understand your pharmacy is out of Trijardy XR. The first step is to check which pharmacies near you have it in stock. You can use medfinder.com — it contacts pharmacies in your area and texts you which ones can fill your prescription. If you're unable to locate it within 1-2 days, please call us back and we'll have the provider review your options."

Proactive Approach: Anticipate Availability Issues Before They Happen

Consider reviewing your patient panel quarterly to identify patients on high-demand brand medications like Trijardy XR and proactively discuss mail-order and alternatives. For a deeper clinical review of the availability situation, see our Trijardy XR shortage provider clinical brief.